Haloperidol Decanoate Side Effects

8328450-1 | Skin Discolouration
on May 02, 2012 Female patient from UNITED STATES , 49 years of age, was diagnosed with schizophrenia, paranoid type and was treated with Haloperidol Decanoate(View Usage). Patient experienced the following unwanted or unexpected effects: skin discolouration. Haloperidol Decanoate dosage: |dosagetext: 100 Mg/ml||strength: 100 Mg/ml||freq: Q4 Weeks||route: Intramuscular|.

8309701-6 | Stupor, Fall, Pulmonary Embolism, Hallucination, Auditory, Blood Glucose Increased, Unresponsive To Stimuli, Catatonia, Blood Pressure Decreased, Cardio-respiratory Arrest
Patient was taking Haloperidol Decanoate (View Usage). Patient had the following side effects: stupor, fall (What is fall?), pulmonary embolism (What is pulmonary embolism?), hallucination, auditory, blood glucose increased, unresponsive to stimuli, catatonia, blood pressure decreased, cardio-respiratory arrest on Apr 12, 2012 from UNITED STATES Additional patient health information: Female patient , 27 years of age, was diagnosed with depression (What is depression?) and. Haloperidol Decanoate dosage: 5 Mg Im. During the same period patient was treated with LORAZEPAM (2 Mg Im) (View Lorazepam Review and Lorazepam Label ). Patient was hospitalized.

8219241-0 |
Adverse event was reported on Mar 06, 2012 by a Male patient taking Haloperidol Decanoate (View Usage) (Dosage: Unk Unk, Single) was diagnosed with schizophrenia and. Location: LITHUANIA , 28 years of age, . During the same period patient was treated with OLANZAPINE (300 Mg, Every 2 Weeks) (View Olanzapine Review and Olanzapine Label ).

8184476-2 | Influenza, Bronchitis, Neuroleptic Malignant Syndrome, Head Injury
on Feb 23, 2012 Male patient from JAPAN , weighting 149.9 lb, was diagnosed with schizophrenia, paranoid type, gastritis, anxiety (What is anxiety?), depression (What is depression?), prophylaxis and was treated with Haloperidol Decanoate (View Usage). Patient experienced the following unwanted or unexpected effects: influenza, bronchitis (What is bronchitis?), neuroleptic malignant syndrome, head injury. Haloperidol Decanoate dosage: . During the same period patient was treated with INVEGA (View Invega Review and Invega Label ), SELBEX (View Selbex Review and Selbex Label ), LUVOX (View Luvox Review and Luvox Label ), DIAZEPAM (View Diazepam Review and Diazepam Label ), RIZE (View Rize Review and Rize Label ), AKINETON (View Akineton Review and Akineton Label ). Patient was hospitalized.


8179620-7 | Neuroleptic Malignant Syndrome, Heart Rate Increased, Blood Pressure Increased
on Feb 29, 2012 Male patient from UNITED STATES , weighting 135.4 lb, was diagnosed with schizophrenia and was treated with Haloperidol Decanoate(View Usage). Patient had the following side effects: neuroleptic malignant syndrome, heart rate increased, blood pressure increased. Haloperidol Decanoate dosage: Haloperidol Decanoate 100 Mg Q Week Im. During the same period patient was treated with DIPHENHYDRAMINE HCL (View Diphenhydramine Hcl Review and Diphenhydramine Hcl Label ), HALOPERIDOL LACTATE (Haloperidol Lactate 5-10 Mg Qid Prn Im) (View Haloperidol Lactate Review and Haloperidol Lactate Label ), LORAZEPAM (View Lorazepam Review and Lorazepam Label ). Patient was hospitalized.

8173772-0 | Depressed Level Of Consciousness, Overdose, Fatigue, Unresponsive To Stimuli
Patient was taking Haloperidol Decanoate (View Usage). After Haloperidol Decanoate was administered, patient had the following side effects: depressed level of consciousness, overdose, fatigue, unresponsive to stimuli on Feb 15, 2012 from UNITED STATES Additional patient health information: Female patient , 39 years of age, was diagnosed with bipolar disorder (What is bipolar disorder?), depression (What is depression?), anxiety (What is anxiety?) and. Haloperidol Decanoate dosage: 5 Mg At Bedtime. During the same period patient was treated with BUPRENORPHINE HCL (4 Mg, Sublingually, 8 Mg) (View Buprenorphine Hcl Review and Buprenorphine Hcl Label ). Patient was hospitalized.

8160421-0 | Loss Of Consciousness, Overdose, Delirium, Psychotic Disorder
Adverse event was reported on Feb 21, 2012 by a Male patient taking Haloperidol Decanoate (View Usage) (Dosage: 100 Mg, Monthly) was diagnosed with schizoaffective disorder, pain (What is pain?), insomnia and. Location: UNITED STATES , 69 years of age, Patient experienced the following unwanted or unexpected effects: loss of consciousness, overdose, delirium, psychotic disorder (What is psychotic disorder?). During the same period patient was treated with NAPROXEN (View Naproxen Review and Naproxen Label ), ZOLPIDEM TARTRATE (View Zolpidem Tartrate Review and Zolpidem Tartrate Label ), DULOXETIME HYDROCHLORIDE (60 Mg, Daily) (View Duloxetime Hydrochloride Review and Duloxetime Hydrochloride Label ).

8015497-8 | Neuroleptic Malignant Syndrome, Abnormal Behaviour, Colitis Ischaemic, Diarrhoea Haemorrhagic, Psychomotor Hyperactivity
on Dec 12, 2011 Male patient from PORTUGAL , 32 years of age, was diagnosed with mental retardation and was treated with Haloperidol Decanoate (View Usage). Patient had the following side effects: neuroleptic malignant syndrome, abnormal behaviour, colitis ischaemic, diarrhoea haemorrhagic, psychomotor hyperactivity. Haloperidol Decanoate dosage: 100 Mg, 10 Days. Patient was hospitalized.

7984661-6 | Dysphagia
on Dec 09, 2011 Male patient from INDIA , 37 years of age, was diagnosed with schizophrenia and was treated with Haloperidol Decanoate(View Usage). After Haloperidol Decanoate was administered, patient had the following side effects: dysphagia. Haloperidol Decanoate dosage: .

7943677-6 | Injection Site Pain, Ejaculation Disorder, Tremor
Patient was taking Haloperidol Decanoate (View Usage). Patient experienced the following unwanted or unexpected effects: injection site pain, ejaculation disorder, tremor on Nov 16, 2011 from JAPAN Additional patient health information: Male patient , 48 years of age, was diagnosed with schizophrenia and. Haloperidol Decanoate dosage: . During the same period patient was treated with RISPERDAL (View Risperdal Review and Risperdal Label ), RISPERDAL CONSTA (View Risperdal Consta Review and Risperdal Consta Label ). Patient was hospitalized.

7940861-2 | Visual Impairment, Fall, Eye Irritation, Balance Disorder, Eyelid Ptosis
Adverse event was reported on Nov 17, 2011 by a Male patient taking Haloperidol Decanoate (View Usage) (Dosage: ) was diagnosed with schizophrenia and. Location: JAPAN , 33 years of age, Patient had the following side effects: visual impairment, fall (What is fall?), eye irritation, balance disorder, eyelid ptosis. During the same period patient was treated with SYMMETREL (View Symmetrel Review and Symmetrel Label ), CLONAZEPAM (View Clonazepam Review and Clonazepam Label ), LONASEN (View Lonasen Review and Lonasen Label ), TASMOLIN (View Tasmolin Review and Tasmolin Label ).

7917041-X | Agranulocytosis, Neutrophil Count Decreased, Withdrawal Syndrome, Sedation, Psychotic Disorder, Extrapyramidal Disorder
on Oct 29, 2011 Female patient from CANADA , 41 years of age, was diagnosed with schizophrenia, paranoid type and was treated with Haloperidol Decanoate (View Usage). After Haloperidol Decanoate was administered, patient had the following side effects: agranulocytosis, neutrophil count decreased, withdrawal syndrome, sedation, psychotic disorder (What is psychotic disorder?), extrapyramidal disorder. Haloperidol Decanoate dosage: Im. During the same period patient was treated with RISPERIDONE (4 Mg; 2 Mg; 4 Mg; 6 Mg; 10 Mg) (View Risperidone Review and Risperidone Label ), CLOZAPINE (600 Mg; 400 Mg) (View Clozapine Review and Clozapine Label ).

7914202-0 | Sedation, Somnolence, Incorrect Dose Administered
on Nov 07, 2011 Female patient from IRELAND , 54 years of age, was diagnosed with schizophrenia, psychotic disorder (What is psychotic disorder?), extrapyramidal disorder, affective disorder, gastrooesophageal reflux disease and was treated with Haloperidol Decanoate(View Usage). Patient experienced the following unwanted or unexpected effects: sedation, somnolence, incorrect dose administered. Haloperidol Decanoate dosage: . During the same period patient was treated with TRIFLUOPERAZINE HCL (View Trifluoperazine Hcl Review and Trifluoperazine Hcl Label ), LAMISIL (View Lamisil Review and Lamisil Label ), VALPROATE SODIUM (View Valproate Sodium Review and Valproate Sodium Label ), PALIPERIDONE (View Paliperidone Review and Paliperidone Label ), BIPERIDEN HYDROCHLORIDE TAB (View Biperiden Hydrochloride Tab Review and Biperiden Hydrochloride Tab Label ), LAMOTRIGINE (View Lamotrigine Review and Lamotrigine Label ), NEXIUM (View Nexium Review and Nexium Label ).

7900441-1 | Eye Irritation, Visual Impairment, Fall, Balance Disorder, Eyelid Ptosis
Patient was taking Haloperidol Decanoate (View Usage). Patient had the following side effects: eye irritation, visual impairment, fall (What is fall?), balance disorder, eyelid ptosis on Oct 31, 2011 from JAPAN Additional patient health information: Male patient , 33 years of age, was diagnosed with schizophrenia and. Haloperidol Decanoate dosage: . During the same period patient was treated with CLONAZEPAM (View Clonazepam Review and Clonazepam Label ), SYMMETREL (View Symmetrel Review and Symmetrel Label ), TASMOLIN (View Tasmolin Review and Tasmolin Label ), LONASEN (View Lonasen Review and Lonasen Label ).

7842048-0 | Sedation, Somnolence, Incorrect Dose Administered
Adverse event was reported on Oct 13, 2011 by a Female patient taking Haloperidol Decanoate (View Usage) (Dosage: ) was diagnosed with schizophrenia, extrapyramidal disorder, gastrooesophageal reflux disease, affective disorder, psychotic disorder (What is psychotic disorder?) and. Location: IRELAND , 54 years of age, After Haloperidol Decanoate was administered, patient had the following side effects: sedation, somnolence, incorrect dose administered. During the same period patient was treated with BIPERIDEN HYDROCHLORIDE TAB (View Biperiden Hydrochloride Tab Review and Biperiden Hydrochloride Tab Label ), NEXIUM (View Nexium Review and Nexium Label ), LAMISIL (View Lamisil Review and Lamisil Label ), VALPROATE SODIUM (View Valproate Sodium Review and Valproate Sodium Label ), LAMOTRIGINE (View Lamotrigine Review and Lamotrigine Label ), PALIPERIDONE (View Paliperidone Review and Paliperidone Label ), TRIFLUOPERAZINE HCL (View Trifluoperazine Hcl Review and Trifluoperazine Hcl Label ).

7799652-8 | White Blood Cell Count Decreased, Neutrophil Count Decreased, Extrapyramidal Disorder, Psychiatric Symptom, Agranulocytosis, Sedation
on Sep 28, 2011 Female patient from CANADA , 41 years of age, was diagnosed with schizophrenia and was treated with Haloperidol Decanoate (View Usage). Patient experienced the following unwanted or unexpected effects: white blood cell count decreased, neutrophil count decreased, extrapyramidal disorder, psychiatric symptom, agranulocytosis, sedation. Haloperidol Decanoate dosage: . During the same period patient was treated with LAMOTRIGINE (150 Mg,) (View Lamotrigine Review and Lamotrigine Label ), CLOZAPINE (View Clozapine Review and Clozapine Label ), RISPERDAL (View Risperdal Review and Risperdal Label ), RISPERIDONE (View Risperidone Review and Risperidone Label ). Patient was hospitalized.

7757135-5 | Blood Creatine Phosphokinase Increased, Camptocormia
on Jun 15, 2011 Female patient from UNITED STATES , 73 years of age, was treated with Haloperidol Decanoate(View Usage). Patient had the following side effects: blood creatine phosphokinase increased, camptocormia. Haloperidol Decanoate dosage: . During the same period patient was treated with ZYPREXA (5 Mg, Daily (1/d)) (View Zyprexa Review and Zyprexa Label ). Patient was hospitalized.

7631412-0 | Anaphylactic Reaction
Patient was taking Haloperidol Decanoate (View Usage). After Haloperidol Decanoate was administered, patient had the following side effects: anaphylactic reaction on Jul 18, 2011 from UNITED STATES Additional patient health information: Female patient , 61 years of age, . Haloperidol Decanoate dosage: .

7609128-6 | Pancreatitis Acute
Adverse event was reported on Jul 11, 2011 by a Male patient taking Haloperidol Decanoate (View Usage) (Dosage: ) . Location: GERMANY , 48 years of age, Patient experienced the following unwanted or unexpected effects: pancreatitis acute. During the same period patient was treated with VALPROATE SODIUM (View Valproate Sodium Review and Valproate Sodium Label ). Patient was hospitalized.

7579207-0 | Blood Creatine Phosphokinase Increased, Camptocormia
on Jun 15, 2011 Female patient from UNITED STATES , 73 years of age, was treated with Haloperidol Decanoate (View Usage). Patient had the following side effects: blood creatine phosphokinase increased, camptocormia. Haloperidol Decanoate dosage: . During the same period patient was treated with ZYPREXA (5 Mg, Daily (1/d)) (View Zyprexa Review and Zyprexa Label ). Patient was hospitalized.

7545708-4 | Injection Site Oedema, Injection Site Warmth, Injection Site Pain
on Jun 13, 2011 Male patient from UNITED STATES , 33 years of age, weighting 150.0 lb, was diagnosed with schizophrenia and was treated with Haloperidol Decanoate(View Usage). After Haloperidol Decanoate was administered, patient had the following side effects: injection site oedema, injection site warmth, injection site pain. Haloperidol Decanoate dosage: 150mg Q 4 Weeks Im Greater Than 5 Years.

7487449-8 | Cholestasis, Hepatotoxicity
Patient was taking Haloperidol Decanoate (View Usage). Patient experienced the following unwanted or unexpected effects: cholestasis, hepatotoxicity on Apr 27, 2011 from SERBIA Additional patient health information: Male patient , 43 years of age, . Haloperidol Decanoate dosage: .

7404865-0 | Abdominal Pain, Neuroleptic Malignant Syndrome, Abdominal Distension, Mutism, Diarrhoea Haemorrhagic
Adverse event was reported on Mar 28, 2011 by a Male patient taking Haloperidol Decanoate (View Usage) (Dosage: ) was diagnosed with aggression and. Location: PORTUGAL , 32 years of age, Patient had the following side effects: abdominal pain (What is abdominal pain?), neuroleptic malignant syndrome, abdominal distension, mutism, diarrhoea haemorrhagic. During the same period patient was treated with LEVOMEPROMAZINE (View Levomepromazine Review and Levomepromazine Label ), OXAZEPAM (View Oxazepam Review and Oxazepam Label ), QUETIAPINE (View Quetiapine Review and Quetiapine Label ), OLANZAPINE (View Olanzapine Review and Olanzapine Label ). Patient was hospitalized.

7372457-8 | Neuroleptic Malignant Syndrome, Mutism
on Mar 15, 2011 Male patient from PORTUGAL , 32 years of age, was diagnosed with aggression and was treated with Haloperidol Decanoate (View Usage). After Haloperidol Decanoate was administered, patient had the following side effects: neuroleptic malignant syndrome, mutism. Haloperidol Decanoate dosage: .

7208873-4 | Neurological Symptom
on Dec 24, 2010 Male patient from JAPAN , 50 years of age, was diagnosed with ill-defined disorder and was treated with Haloperidol Decanoate(View Usage). Patient experienced the following unwanted or unexpected effects: neurological symptom. Haloperidol Decanoate dosage: . During the same period patient was treated with RISPERDAL (View Risperdal Review and Risperdal Label ), FLUVOXAMINE MALEATE (View Fluvoxamine Maleate Review and Fluvoxamine Maleate Label ). Patient was hospitalized.

7074363-5 | Neuroleptic Malignant Syndrome
Patient was taking Haloperidol Decanoate (View Usage). Patient had the following side effects: neuroleptic malignant syndrome on Oct 07, 2010 from UNITED STATES Additional patient health information: Female patient , 39 years of age, was diagnosed with agitation, bipolar i disorder and. Haloperidol Decanoate dosage: 7 Mg;qd;im. During the same period patient was treated with LITHIUM CARBONATE CAP (600 Mg;qd ; 450 Mg;qd) (View Lithium Carbonate Cap Review and Lithium Carbonate Cap Label ), CLOZAPINE (200 Mg 1x ; 275 Mg;qd ; 37.5 Mg;qd ; 400 Mg;qd) (View Clozapine Review and Clozapine Label ), VALPROIC ACID SYRUP (700 Mg;qd) (View Valproic Acid Syrup Review and Valproic Acid Syrup Label ), PIPAMPERONE (80 Mg;qd) (View Pipamperone Review and Pipamperone Label ), DIAZEPAM (View Diazepam Review and Diazepam Label ), LEVOTHYROXINE (View Levothyroxine Review and Levothyroxine Label ). Patient was hospitalized.

7074169-7 | Catatonia, Condition Aggravated, Immobile, Musculoskeletal Stiffness, Mutism, Neuroleptic Malignant Syndrome, Psychotic Disorder, Tremor
Adverse event was reported on Oct 07, 2010 by a Female patient taking Haloperidol Decanoate (View Usage) (Dosage: 600 Mg;qd ; 7 Mg;qd;im) was diagnosed with agitation, bipolar i disorder, psychotic disorder (What is psychotic disorder?) and. Location: UNITED STATES , 39 years of age, After Haloperidol Decanoate was administered, patient had the following side effects: catatonia, condition aggravated, immobile, musculoskeletal stiffness, mutism, neuroleptic malignant syndrome, psychotic disorder (What is psychotic disorder?), tremor. During the same period patient was treated with LITHIUM CARBONATE CAP (600 Mg;qd ; 450 Mg;qd) (View Lithium Carbonate Cap Review and Lithium Carbonate Cap Label ), CLOZAPINE (200 Mg;1x ; 275 Mg;qd ; 37.5 Mg;qd ; 400 Mg;qd) (View Clozapine Review and Clozapine Label ), VALPROIC ACID SYRUP (700 Mg;qd) (View Valproic Acid Syrup Review and Valproic Acid Syrup Label ), PIPAMPERONE (80 Mg;qd) (View Pipamperone Review and Pipamperone Label ), DIAZEPAM (View Diazepam Review and Diazepam Label ). Patient was hospitalized.

7051793-9 | Abdominal Distension, Blood Potassium Decreased, Catatonia, Gastrointestinal Hypomotility, Middle Insomnia, Neuroleptic Malignant Syndrome, Psychotic Disorder
on Sep 25, 2010 Female patient from UNITED STATES , 39 years of age, was diagnosed with bipolar i disorder, agitation and was treated with Haloperidol Decanoate (View Usage). Patient experienced the following unwanted or unexpected effects: abdominal distension, blood potassium decreased, catatonia, gastrointestinal hypomotility, middle insomnia, neuroleptic malignant syndrome, psychotic disorder (What is psychotic disorder?). Haloperidol Decanoate dosage: 7 Mg;qd;im. During the same period patient was treated with LITHIUM CARBONATE CAP (600 Mg;qd) (View Lithium Carbonate Cap Review and Lithium Carbonate Cap Label ), CLOZAPINE (View Clozapine Review and Clozapine Label ), VALPROIC ACID SYRUP (View Valproic Acid Syrup Review and Valproic Acid Syrup Label ), PIPAMPERONE (View Pipamperone Review and Pipamperone Label ), DIAZEPAM (View Diazepam Review and Diazepam Label ). Patient was hospitalized.

6831210-1 | Agitation, Arrhythmia, Cardiac Arrest, Syncope, Ventricular Fibrillation
on Jul 02, 2010 Female patient from UNITED STATES , 43 years of age, was diagnosed with agitation and was treated with Haloperidol Decanoate(View Usage). Patient had the following side effects: agitation, arrhythmia (What is arrhythmia?), cardiac arrest (What is cardiac arrest?), syncope, ventricular fibrillation. Haloperidol Decanoate dosage: . During the same period patient was treated with OLANZAPINE (View Olanzapine Review and Olanzapine Label ), LORAZEPAM (View Lorazepam Review and Lorazepam Label ).

6768191-5 | Dyskinesia, Dystonia, Incorrect Dose Administered
Patient was taking Haloperidol Decanoate (View Usage). After Haloperidol Decanoate was administered, patient had the following side effects: dyskinesia, dystonia (What is dystonia?), incorrect dose administered on Jun 03, 2010 from Additional patient health information: Male patient , child 5 years of age, was diagnosed with back pain (What is back pain?) and. Haloperidol Decanoate dosage: 10mg/x Three Times A Day/ Oral.

6732825-1 | Blood Pressure Diastolic Decreased, Crepitations, Dyspnoea, Electrocardiogram St Segment Depression, Electrocardiogram T Wave Inversion, Extrasystoles, Haemoglobin Decreased, Heart Rate Irregular, Hypoventilation
Adverse event was reported on May 10, 2010 by a Female patient taking Haloperidol Decanoate (View Usage) (Dosage: 80 Mg) was diagnosed with schizophrenia and. Location: INDIA , 65 years of age, Patient experienced the following unwanted or unexpected effects: blood pressure diastolic decreased, crepitations, dyspnoea, electrocardiogram st segment depression, electrocardiogram t wave inversion, extrasystoles, haemoglobin decreased, heart rate irregular, hypoventilation. Patient was hospitalized.

6608652-2 | Rash Erythematous
on Feb 26, 2010 Male patient from UNITED STATES , 41 years of age, weighting 179.0 lb, was treated with Haloperidol Decanoate (View Usage). Patient had the following side effects: rash erythematous. Haloperidol Decanoate dosage: 100mg Im.

6570341-0 | Myocardial Infarction
on Feb 01, 2010 Female patient from UNITED KINGDOM , 55 years of age, was treated with Haloperidol Decanoate(View Usage). After Haloperidol Decanoate was administered, patient had the following side effects: myocardial infarction. Haloperidol Decanoate dosage: .

6549032-8 | Atrial Flutter, Respiratory Failure
Patient was taking Haloperidol Decanoate (View Usage). Patient experienced the following unwanted or unexpected effects: atrial flutter, respiratory failure on Jan 20, 2010 from UNITED STATES Additional patient health information: Male patient , weighting 174.0 lb, was diagnosed with agitation and. Haloperidol Decanoate dosage: . During the same period patient was treated with ZYPREXA (View Zyprexa Review and Zyprexa Label ), ATIVAN (View Ativan Review and Ativan Label ), LIPITOR (View Lipitor Review and Lipitor Label ), LOPRESSOR (View Lopressor Review and Lopressor Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), LOVENOX (View Lovenox Review and Lovenox Label ), NEXIUM (View Nexium Review and Nexium Label ), LISINOPRIL (View Lisinopril Review and Lisinopril Label ).

6547719-4 | Amnesia, Disturbance In Attention, Dyskinesia
Adverse event was reported on Jan 15, 2010 by a Male patient taking Haloperidol Decanoate (View Usage) (Dosage: ) was diagnosed with schizophrenia and. Location: PORTUGAL , 36 years of age, Patient had the following side effects: amnesia, disturbance in attention, dyskinesia.

6518519-6 | Hospitalisation, Hypertension, Hypothyroidism, Product Container Issue
on Dec 17, 2009 Female patient from UNITED STATES , weighting 134.0 lb, was diagnosed with schizophrenia and was treated with Haloperidol Decanoate (View Usage). After Haloperidol Decanoate was administered, patient had the following side effects: hospitalisation, hypertension, hypothyroidism, product container issue. Haloperidol Decanoate dosage: . Patient was hospitalized.

6518040-5 | Uveitis
on Dec 15, 2009 Male patient from GERMANY , weighting 154.3 lb, was diagnosed with schizoaffective disorder and was treated with Haloperidol Decanoate(View Usage). Patient experienced the following unwanted or unexpected effects: uveitis. Haloperidol Decanoate dosage: . During the same period patient was treated with ZYPREXA (View Zyprexa Review and Zyprexa Label ), CARBAMAZEPINE (View Carbamazepine Review and Carbamazepine Label ), JODTHYROX (View Jodthyrox Review and Jodthyrox Label ).

6473697-2 | Amenorrhoea, Hyperprolactinaemia, Osteopenia
Patient was taking Haloperidol Decanoate (View Usage). Patient had the following side effects: amenorrhoea, hyperprolactinaemia, osteopenia on Nov 27, 2009 from UNITED KINGDOM Additional patient health information: Female patient , 58 years of age, was diagnosed with schizophrenia, paranoid type and. Haloperidol Decanoate dosage: . During the same period patient was treated with TRIFLUOPERAZINE (View Trifluoperazine Review and Trifluoperazine Label ).

6473696-0 | Uveitis
Adverse event was reported on Nov 27, 2009 by a Male patient taking Haloperidol Decanoate (View Usage) (Dosage: ) . Location: GERMANY , 50 years of age, After Haloperidol Decanoate was administered, patient had the following side effects: uveitis.

6431991-5 | Pulmonary Embolism
on Nov 04, 2009 Female patient from GERMANY , 68 years of age, was treated with Haloperidol Decanoate (View Usage). Patient experienced the following unwanted or unexpected effects: pulmonary embolism (What is pulmonary embolism?). Haloperidol Decanoate dosage: . During the same period patient was treated with OLANZAPINE (View Olanzapine Review and Olanzapine Label ), DOXEPIN HCL (View Doxepin Hcl Review and Doxepin Hcl Label ), BIPERIDEN HYDROCHLORIDE TAB (View Biperiden Hydrochloride Tab Review and Biperiden Hydrochloride Tab Label ), LORAZEPAM (View Lorazepam Review and Lorazepam Label ).

6426205-6 | Blood Pressure Abnormal, Extrapyramidal Disorder, Mean Cell Volume Increased, Neuroleptic Malignant Syndrome, Urinary Incontinence
on Oct 30, 2009 Male patient from UNITED KINGDOM , 17 years of age, weighting 132.3 lb, was diagnosed with sedation, schizophrenia and was treated with Haloperidol Decanoate(View Usage). Patient had the following side effects: blood pressure abnormal, extrapyramidal disorder, mean cell volume increased, neuroleptic malignant syndrome, urinary incontinence (What is urinary incontinence?). Haloperidol Decanoate dosage: . During the same period patient was treated with CLOZARIL (View Clozaril Review and Clozaril Label ), CITALOPRAM (View Citalopram Review and Citalopram Label ).

6426203-2 | Muscle Twitching, Weight Increased
Patient was taking Haloperidol Decanoate (View Usage). After Haloperidol Decanoate was administered, patient had the following side effects: muscle twitching, weight increased on Oct 27, 2009 from BRAZIL Additional patient health information: Female patient , 42 years of age, weighting 264.6 lb, was diagnosed with schizophrenia and. Haloperidol Decanoate dosage: .

6413951-3 | Hospitalisation, Hyperprolactinaemia
Adverse event was reported on Oct 16, 2009 by a Male patient taking Haloperidol Decanoate (View Usage) (Dosage: ) was diagnosed with bipolar i disorder and. Location: UNITED STATES , 29 years of age, Patient experienced the following unwanted or unexpected effects: hospitalisation, hyperprolactinaemia. Patient was hospitalized.

6369521-9 | Amnesia, Disturbance In Attention, Dyskinesia
on Sep 15, 2009 Male patient from PORTUGAL , 36 years of age, was diagnosed with schizophrenia and was treated with Haloperidol Decanoate (View Usage). Patient had the following side effects: amnesia, disturbance in attention, dyskinesia. Haloperidol Decanoate dosage: .

6339397-4 | Psychotic Disorder
on Aug 28, 2009 Female patient from ARGENTINA , 30 years of age, was treated with Haloperidol Decanoate(View Usage). After Haloperidol Decanoate was administered, patient had the following side effects: psychotic disorder (What is psychotic disorder?). Haloperidol Decanoate dosage: . During the same period patient was treated with OLANZAPINE (View Olanzapine Review and Olanzapine Label ). Patient was hospitalized.

6317464-9 | Dyskinesia, Hypotension, Myoclonus, Overdose, Sopor
Patient was taking Haloperidol Decanoate (View Usage). Patient experienced the following unwanted or unexpected effects: dyskinesia, hypotension, myoclonus, overdose, sopor on Aug 14, 2009 from ITALY Additional patient health information: Female patient , 75 years of age, . Haloperidol Decanoate dosage: 3 Vials, 50 Mg/3ml,.

6308537-5 | Dyskinesia, Hypotension, Myoclonus, Overdose, Sopor
Adverse event was reported on Aug 06, 2009 by a Female patient taking Haloperidol Decanoate (View Usage) (Dosage: 3 Vials, 50 Mg/3ml,) . Location: ITALY , 75 years of age, Patient had the following side effects: dyskinesia, hypotension, myoclonus, overdose, sopor.

6293685-9 | Cholestatic Liver Injury, Hepatitis, Psychotic Disorder
on Jun 09, 2009 Male patient from GERMANY , weighting 127.9 lb, was diagnosed with schizophrenia, paranoid type and was treated with Haloperidol Decanoate (View Usage). After Haloperidol Decanoate was administered, patient had the following side effects: cholestatic liver injury, hepatitis (What is hepatitis?), psychotic disorder (What is psychotic disorder?). Haloperidol Decanoate dosage: . During the same period patient was treated with INSULIN (View Insulin Review and Insulin Label ). Patient was hospitalized.

6282730-2 | Anhedonia, Apathy, Fatigue, Schizophrenia, Somnolence, Treatment Noncompliance, Weight Increased
on Jul 15, 2009 Female patient from PORTUGAL , 37 years of age, was diagnosed with schizophrenia and was treated with Haloperidol Decanoate(View Usage). Patient experienced the following unwanted or unexpected effects: anhedonia, apathy, fatigue, schizophrenia, somnolence, treatment noncompliance, weight increased. Haloperidol Decanoate dosage: . During the same period patient was treated with RISPERIDONE (View Risperidone Review and Risperidone Label ), LORAZEPAM (View Lorazepam Review and Lorazepam Label ). Patient was hospitalized.

6282470-X | Injection Site Reaction, Musculoskeletal Stiffness, Procedural Complication, Restlessness, Schizophrenia
Patient was taking Haloperidol Decanoate (View Usage). Patient had the following side effects: injection site reaction, musculoskeletal stiffness, procedural complication, restlessness, schizophrenia on Jun 25, 2009 from UNITED STATES Additional patient health information: Male patient , 57 years of age, weighting 133.0 lb, was diagnosed with schizophrenia, insomnia, gastric disorder, gastrooesophageal reflux disease, hypertension, musculoskeletal stiffness and. Haloperidol Decanoate dosage: . During the same period patient was treated with RISPERDAL (View Risperdal Review and Risperdal Label ), TRAZODONE (View Trazodone Review and Trazodone Label ), RANITIDINE (View Ranitidine Review and Ranitidine Label ), OMEPRAZOLE (View Omeprazole Review and Omeprazole Label ), LISINOPRIL (View Lisinopril Review and Lisinopril Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), POTASSIUM CHLORIDE (View Potassium Chloride Review and Potassium Chloride Label ), COGENTIN (View Cogentin Review and Cogentin Label ). Patient was hospitalized.